Intermittent pneumatic compression (IPC) applied to lower limbs is becoming a popular post exercise recovery technique; however, it still lacks strong scientific support. The purpose of this systematic review and meta-analysis was to analyse the effects of lower-limb IPC on sports recovery, as...
1 September 2024 in International Journal of Sports Physiology and Performance
Purpose
:
There are multiple postexercise recovery technologies available in the market based on the assumption of blood-flow enhancement. Lower-limb intermittent pneumatic compression (IPC) has been widely used, but the available scientific evidence supporting its effectiveness remains scarce, requiring a deeper investigation into its underlying mechanisms. The aim of this study was to assess the hemodynamic effects caused by the use of IPC at rest. Methods
:
Twenty-two soccer and track and field athletes underwent two 15-minute IPC protocols (moderate- [80 mm Hg] and high-pressure [200 mm Hg]) in a randomized order. Systolic peak velocity, end-diastolic peak velocity, arterial diameter, and heart rate were measured before, during (at the eighth minute), and 2 minutes after each IPC protocol. Results
:
Significant effects were observed between before and during (eighth minute) the IPC protocol for measures of systolic ( P < .001) and end-diastolic peak velocities ( P < .001), with the greater effects observed during the high-pressure protocol. Moreover, 2 minutes after each IPC protocol, hemodynamic variables returned to values close to baseline. Arterial diameter presented significant differences between pressures during the IPC protocols ( P < .05), while heart rate remained unaltered. Conclusion
:
IPC effectively enhances transitory blood flow of athletes, particularly when applying high-pressure protocols.
This study aimed to analyze the associations between recovery of low-frequency fatigue, jump height, and perceptual responses following official soccer matches. Forty-two male youth elite soccer players (age: 17.13±0.70 years; height: 179.17±5.94 cm; weight: 69.74±4.91 kg) participated in this study. Low-frequency fatigue, countermovement jump, perceived fatigue, muscle soreness, and perceived recovery were assessed at − 2 h, +30 min, +24 h and +48 h relative to the match. Linear mixed models analysis showed that low-frequency fatigue was reduced at the match-end (ES=− 0.679 [95% CI =− 1.01; − 0.34]; p<0.001) but returned to baseline after 24 h (ES=0.149 [95% CI = − 0.26; 0.56]; p=1.00). Perceptual responses were impaired for up to 48 hours following the match (ES=− 0.868–1.174; p0.05). Additionally, the within-subject correlation analysis showed that low-frequency fatigue pre- to post-match changes presented moderate to large associations with perceived fatigue (rm[57]=− 0.43; p<0.001), muscle soreness (rm[57]=− 0.52; p<0.001), and perceived recovery (rm[57]=0.38; p=0.003). The assessment of low-frequency fatigue could serve as an additional objective measurement for monitoring post-match fatigue, as findings suggest that young elite soccer players experience transient reductions following match-play, which are strongly correlated with subjective markers of recovery.
Ergogenic supplements are becoming increasingly popular in the diet of trained individuals, due to their potential benefits. Ashwagandha (Withania somnifera) is one of the supplements that has recently grown in popularity. Despite growing interest, its scientific background remains limited and sometimes inconsistent. Objective: This overview of systematic reviews aimed to evaluate the effects of Ashwagandha supplementation on sports performance and health-related outcomes. Methods: A systematic literature search was carried out on the following electronic databases: PUBMed, Scopus, Academic Search Complete, SPORTDiscus, Web of Science, and Google Scholar, using the search terms “ashwagandha” and “systematic review” in the title or abstract of the publication in July 2024. The eligibility of the articles was assessed using the PICOS (Population, Intervention, Comparator, Outcomes, and Study Design) approach, and risk of bias was assessed using the AMSTAR-2 checklist. Results: Of the 2388 systematic reviews found, 11 met the inclusion criteria, which included 151 original studies representing 9005 individuals. Findings suggest that Ashwagandha supplementation may improve various aspects of sports performance, such as endurance and muscular strength, as well as health-related outcomes, including anxiety reduction, improved sleep quality, and enhanced sexual function. The most commonly used doses of Ashwagandha supplementation are between 500 mg and 1000 mg a day. Conclusion: While current evidence indicates promising effects of Ashwagandha on physical and psychological parameters, further high-quality randomized controlled trials are needed. Therefore, its use in athletes or healthy individuals should be considered with caution and based on individual needs.
1 August 2025 in International Journal of Sports Physiology and Performance
Purpose: This study aimed to investigate the impact of an intermittent pneumatic compression (IPC) protocol on the recovery kinetics following exercise-induced muscle damage caused by an all-out flywheel protocol consisting of 6 sets of 12-repetition squats. Methods: Thirty-three active male university students (age 20.85 [2.8] y, height 178 [5.7] cm, body mass 75.05 [7.54] kg) were randomly assigned to either a 30-minute peristaltic IPC treatment at 200 mm Hg or a 30-minute placebo intervention (ie, simulated microcurrent treatment). Participants performed functional tests, including maximal knee extension and flexion, countermovement jump, and broad jump, and completed a perceptual soreness questionnaire before the fatigue protocol, immediately after the 30-minute recovery intervention and 24 and 48 hours postintervention. To examine the effects of the fatigue protocol and recovery interventions, a 2 × 4 repeated-measures analysis of variance was conducted, and effect sizes were calculated to assess practical relevance. Results: A significant time effect was observed for all measurements (: .216–.697; P < .05), indicating substantial fatigue from the exercise-induced-muscle-damage protocol. However, no statistically significant differences were detected between recovery interventions (: .001–.130; P: .155–.859). Notably, based on the effect-size analysis, a consistent trend toward reduced perceived soreness with IPC was observed, which may hold practical relevance for athletes (d: 0.32–0.75). Conclusions: Overall, a 30-minute IPC application immediately following exercise-induced muscle damage does not appear to improve the recovery kinetics of jumping and maximal voluntary contraction performance; however, the potential reduction in perceived soreness suggests a need for further investigation.